Thanks Tommy.
Elmiron is available as capsules, and in sc injectable format, although it's not commonly prescribed, and is only approved for the treatment of IC.
My point was that, in my view, $1k - $2k per treatment course, is not a sensible starting point for a revenue projection, if PAR is looking to get this drug available on the PBS.
Thanks Tommy.Elmiron is available as capsules, and in sc...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $78.30K | 269.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12512 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 689 | 3 |
View Market Depth
| Last trade - 14.43pm 08/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |